HIGHTIDE-B (02511) announced its interim results, reporting a loss attributable to shareholders of approximately 146 million yuan, a year-on-year increase of 21.43%.

21:32 31/08/2026

Junsheng Tai Pharmaceutical - B (02511) announced its interim results for 2026, with other income of 3.304 million yuan, a year-on-year decrease of 68.66%; the loss attributable to the companys owners was approximately 146 million yuan, an increase of 21.43% compared to the previous year; the loss per share was 0.29 yuan.

HIGHTIDE-B (02511) announced its interim results for 2026, with other income of 3.304 million yuan, a year-on-year decrease of 68.66%; the loss attributable to shareholders was approximately 146 million yuan, a year-on-year increase of 21.43%; the loss per share was 0.29 yuan.

FLOWING CLOUD (06610) announced its mid-term results, reporting a loss attributable to owners of 14.972 million yuan, narrowing by 87.88% year-on-year.

CHINA WOOD INT(01822) released its interim results, reporting a loss attributable to shareholders of HKD 11.061 million, a year-on-year increase of 1,090.64%.

HEBEI CONS (01727) released its interim results, with a net profit of 58,000 yuan, a year-on-year decrease of 99.94%.

FLOWING CLOUD (06610) announced its mid-term results, reporting a loss attributable to owners of 14.972 million yuan, narrowing by 87.88% year-on-year.

CHINA WOOD INT(01822) released its interim results, reporting a loss attributable to shareholders of HKD 11.061 million, a year-on-year increase of 1,090.64%.

HEBEI CONS (01727) released its interim results, with a net profit of 58,000 yuan, a year-on-year decrease of 99.94%.